SPC manufacturing waiver: export and stockpiling exception to SPC protection

The SPC manufacturing waiver lets EU makers produce a medicine under SPC protection for export, and stockpile it for launch in the final six months.

Also known as: SPC waiver, SPC export waiver, stockpiling waiver, manufacturing waiver

4 min readUpdated

Reviewed by Gosia Luksza, CEO at Regunaut

At a glance

Legal basis
Regulation (EU) 2019/933, amending Regulation (EC) No 469/2009
Export
Making for third countries at any time during the certificate
Stockpiling
Making and storing in the last six months before the certificate expires
Notice
Three months before making starts, to the patent office and the SPC holder

How it works

A supplementary protection certificate (SPC) confers the same rights as the basic patent, so until 2019 nobody could manufacture the protected product in the EU during its term, even for sale in countries where no protection existed. Regulation (EU) 2019/933 amended Article 5 of Regulation (EC) No 469/2009 to create two exceptions, in force since 1 July 2019. A maker established in the EU may make the product, or a medicinal product containing it, for export to third countries at any time during the certificate. In the last six months before the certificate expires, it may also make the product and store it in the Member State of making, in order to place it on the EU market after expiry. Related acts that are strictly necessary for the making, the export or the storing are covered as well.

The waiver comes with conditions. The maker must notify the industrial property office of the Member State where making will take place, and inform the certificate holder, no later than three months before making starts, or before the first related act if that is earlier. The notification, on the standard form annexed to the Regulation, gives the maker's name and address, whether the making is for export, storing or both, the Member States of making and storing, the certificate numbers and, for exports, the reference number of the marketing authorisation in each third country. Products made for export must carry the 'EU export' logo on the outer packaging and, where feasible, on the immediate packaging. The maker must also make sure that those it contracts with know that their acts fall under the waiver and that placing the product on the EU market could infringe the certificate.

The waiver applies only to certificates, not to the basic patent while it is still in force, and only to certificates applied for on or after 1 July 2019, or applied for earlier but taking effect on or after that date; for the second group it has applied since 2 July 2022. Certificates that took effect before 1 July 2019 are outside it. For generic and biosimilar companies the waiver changes the launch calendar: together with the Bolar exemption, which covers development work, it allows commercial batches to be ready on the first day after SPC expiry and allows EU plants to serve export markets earlier.

What goes wrong

A notification that arrives less than three months before the first batch or the first related act, which takes the making outside the waiver; making that starts while the basic patent is still in force; export packs without the logo; stock made for export that is diverted to an EU market; stockpiled product moved to another Member State before expiry; and updates to the notification that are missed when a new export country is added. Originators watch the notifications, which the offices publish, as an early signal of a competitor's plans.

Timing

  1. 3 months before

    Notify the industrial property office and inform the certificate holder.

  2. During the SPC

    Making for export to third countries, with the EU export logo on the packs.

  3. Last 6 months

    Making and storing in the Member State of making, for EU launch.

  4. After expiry

    Stockpiled product can be placed on the EU market.

Notification is due no later than three months before the start of making in the Member State, or before the first related act if that is earlier. Making for export may take place throughout the term of the certificate. Making for storing may start no earlier than six months before the certificate expires, and the stock can be placed on the EU market once the certificate has expired.

SPC manufacturing waiver: common questions

What does the SPC manufacturing waiver allow?

Two things. During the term of a supplementary protection certificate, a maker established in the EU may manufacture the protected product for export to countries outside the EU. In the last six months of the certificate, it may also manufacture and store the product in the Member State of making, so that it can be placed on the EU market as soon as the certificate has expired.

Which SPCs does the manufacturing waiver apply to?

Certificates applied for on or after 1 July 2019, and certificates applied for before that date which took effect on or after it; for that second group the waiver has applied since 2 July 2022. Certificates that had already taken effect before 1 July 2019 are not covered. The waiver does not apply while the basic patent itself is still in force.

Who has to be notified under the SPC waiver, and when?

The maker notifies the industrial property office of the Member State where making will take place and informs the certificate holder, no later than three months before making starts or before the first related act, whichever is earlier. The office publishes the notification. The same information has to be kept up to date, for example when a new export country is added.

Sources

  1. EUR-Lex: Regulation (EU) 2019/933 amending Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products
  2. EUR-Lex: Regulation (EC) No 469/2009 concerning the supplementary protection certificate for medicinal products

Put your SPC manufacturing waiver question to Workbench

Workbench answers regulatory questions from EUR-Lex, EMA, national agencies and your own documents, with every claim linked to its source. Start free with welcome credits.